Advertisement
Product › Details
ZFN™ technology (zinc finger nuclease technology)
Next higher product group | nucleic acid editing technology (DNA/RNA-editing technology) | |
Status | 2008-03-24 development existent | |
Organisation | Sangamo BioSciences Inc. (Nasdaq: SGMO) | |
Today | Sangamo Therapeutics Inc. (Nasdaq: SGMO) | |
Group | Sangamo (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for nucleic acid editing technology (DNA/RNA-editing technology)
- [1] ERS Genomics Ltd.. (3/26/24). "Press Release: Key Charpentier/Doudna CRISPR Patent Upheld by China National Intellectual Property Administration". Dublin....
- [2] ERS Genomics Ltd.. (3/13/24). "Press Release: Ricoh and ERS Genomics Enter into CRISPR/Cas9 License Agreement". Tokyo & Dublin....
- [3] Ansa Biotechnologies, Inc.. (2/22/24). "Press Release: Ansa Biotechnologies Appoints Jason T. Gammack as CEO and Prepares for Launch of Rapid Enzymatic Synthesis Service for Complex DNA Sequences". Emeryville, CA....
- [4] CRISPR Therapeutics AG. (2/13/24). "Press Release: European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, Casgevy (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)". Z...
- [5] Precision BioSciences, Inc.. (2/13/24). "Press Release: Precision BioSciences Promotes Naresh Tanna to Vice President of Investor Relations". Durham, NC....
- [6] CRISPR Therapeutics AG. (2/13/24). "Press Release: CRISPR Therapeutics Announces $280 Million Registered Direct Offering". Zug & Boston, MA....
- [7] Repare Therapeutics Inc.. (2/12/24). "Press Release: Repare Therapeutics to Regain Global Rights to Camonsertib". Cambridge, MA & Montréal....
- [8] Repare Therapeutics Inc.. (1/25/24). "Press Release: Repare Therapeutics Announces Achievement of $40 Million Roche Clinical Milestone Payment". Cambridge, MA & Montréal....
- [9] CRISPR Therapeutics AG. (1/3/24). "Press Release: CRISPR Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference". Zug & Boston, MA....
- [10] Tome Biosciences, Inc.. (1/2/24). "Press Release: Tome Biosciences Acquires Replace Therapeutics". Watertown, MA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top